Standard Pain Management

PreclinicalSmall molecule

HHospital Israelita Albert Einstein

Standard Pain Management is one of 67 small molecule programs targeting Stroke. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

StrokeActive, not recruiting

Diabetes MellitusActive, not recruiting

StrokePreclinical

Active, not recruiting

Diabetes MellitusPreclinical

Active, not recruiting

Competition

Competitive Landscape

461 competitors in Stroke

#DrugCompanyPhaseTrials

Zometa

Pfizer

Preclinical

1 2

Folvite

Eli Lilly

Preclinical

1 3

Proamatine

Pradaxa

3 5

Botox

RRevance Therapeutics, Inc.

Preclinical

2 6

Zantac 150

CChattem

Preclinical

1 7

Haldol

DDePuy Orthopaedics

Preclinical

1 8

Periactin

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

1 9

Inderal

Mylan Pharmaceuticals Inc

Botulinum Toxin a

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Stroke1 trial

Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients

Unknown status·HHospital Israelita Albert Einstein·N/A·NCT04036409·4,369 enrolled

Diabetes Mellitus1 trial

Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)

Active, not recruiting·HHospital Israelita Albert Einstein·N/A·NCT04040634·9,479 enrolled

Sternotomy1 trial

Evaluation of the Effect of Para-sternal Block on Postoperative Respiratory Function After Cardiac Sternotomy Surgery

Active, not recruiting·—·Phase 3·NCT05515809·84 enrolled

Virtual Reality1 trial

e-Natureza Blue Care: Nature-based Virtual Reality and Pain Perception

Not yet recruiting·HHospital Israelita Albert Einstein·N/A·NCT07053228·130 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Standard Pain Management. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Standard Pain Management compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Standard Pain Management. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hospital Israelita Albert Einstein company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: HHospital Israelita Albert Einstein

Standard Pain Management

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Stroke1 trial

Diabetes Mellitus1 trial

Sternotomy1 trial

Virtual Reality1 trial

References

Drug Info

Quick Facts

Related News